Adult nurse practitioners (NPs) and family practice NPs were randomly sampled (N = 411) from the Missouri 2002 list of certified advanced practice nurses. These practitioners were sent a cover letter and the Diseases of Veins Explanation Survey, which was originally developed for assessing patients' explanatory model of the disease. The Diseases of Veins Explanation Survey was tested and revised with professionals (experts) to determine adequate knowledge of the disease. The survey has 5 sections focusing on chronic venous disease: causes, signs, results, treatments, and efficacy of treatments. Section scores and a total score for the participants were calculated by using the expert panel answer model. A total of 138 practitioners responded, with an additional 37 letters returned with an incorrect address, for a total usable response rate of 34%. Demographics of the participants are presented, as well as comparisons between the expert mean section scores and the mean section scores of the NPs. The section scores of the NPs were not significantly different than the section scores of the expert panel; however, the total score of the NPs was significantly different from that of the expert panel ( P =.05). This, plus individual item differences, has implications for NP education and practice.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jvn.2004.06.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A cross-sectional online survey was conducted. A high proportion of the Chinese breast cancer (BC) physician respondents (n=77) would prescribe extended adjuvant endocrine therapy (AET) with aromatase inhibitors (AI) beyond 5 years for postmenopausal females with BC, especially those with higher risk. Respondents with ≥15 years of clinical experience were more likely to prescribe a longer duration of AET for low-risk patients.
View Article and Find Full Text PDFToward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper.
J Am Med Inform Assoc
March 2007
American Medical Informatics Association, 4915 St. Elmo Avenue, Suite 401, Bethesda, MD 20814, USA.
Secondary use of health data applies personal health information (PHI) for uses outside of direct health care delivery. It includes such activities as analysis, research, quality and safety measurement, public health, payment, provider certification or accreditation, marketing, and other business applications, including strictly commercial activities. Secondary use of health data can enhance health care experiences for individuals, expand knowledge about disease and appropriate treatments, strengthen understanding about effectiveness and efficiency of health care systems, support public health and security goals, and aid businesses in meeting customers' needs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!